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Abstract
The Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a variant surface antigen expressed on mature
forms of infected erythrocytes. It is considered an important target of naturally acquired immunity. Despite its extreme
sequence heterogeneity, variants of PfEMP1 can be stratified into distinct groups. Group A PfEMP1 have been
independently associated with low host immunity and severe disease in several studies and are now of potential interest as
vaccine candidates. Although antigen-specific antibodies are considered the main effector mechanism in immunity to
malaria, the induction of efficient and long-lasting antibody responses requires CD4+ T-cell help. To date, very little is known
about CD4+ T-cell responses to PfEMP1 expressed on clinical isolates. The DBLa-tag is a small region from the DBLa-domain
of PfEMP1 that can be amplified with universal primers and is accessible in clinical parasite isolates. We identified the
dominant expressed PfEMP1 in 41 individual clinical parasite isolates and expressed the corresponding DBLa-tag as
recombinant antigen. Individual DBLa-tags were then used to activate CD4+ T-cells from acute and convalescent blood
samples in children who were infected with the respective clinical parasite isolate. Here we show that CD4+ T-cell responses
to the homologous DBLa-tag were induced in almost all children during acute malaria and maintained in some for 4
months. Children infected with parasites that dominantly expressed group A-like PfEMP1 were more likely to maintain
antigen-specific IFNc-producing CD4+ T-cells than children infected with parasites dominantly expressing other PfEMP1.
These results suggest that group A-like PfEMP1 may induce long-lasting effector memory T-cells that might be able to
provide rapid help to variant-specific B cells. Furthermore, a number of children induced CD4+ T-cell responses to
heterologous DBLa-tags, suggesting that CD4+ T-cells may recognise shared epitopes between several DBLa-tags.
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Introduction
Clinical immunity to malaria is achieved only after repeated
infection with Plasmodium falciparum asexual bloodstage parasites.
The Plasmodium falciparum erythrocyte membrane protein 1
(PfEMP1) mediates adhesion of mature forms of infected erythro-
cytes to endothelial cells and is central to pathogenesis and
protective immune responses and also involved in immune evasion.
(reviewed in [1]). Variants of PfEMP1 are encoded by approx-
imately 60 var genes per haploid genome which undergo clonal
antigenic variation and are extremely diverse both within and
between parasite isolates [2]. In children living in malaria- endemic
areas, repeated exposure to a wide range of different PfEMP1
expressed on parasite isolates results in the acquisition of a
repertoire of antibodies against different variants that is associated
with protection [3,4]. Furthermore, parasite isolates from children
suffering from severe malaria or non-immune children were more
likely to be recognised by sera from semi-immune children
suggesting that parasites from non-immune children and those
with severe disease express antigenically restricted repertoires of
PfEMP1 [5,6].
With the whole genome sequence of the laboratory isolate 3D7
it became evident that var genes encoding PfEMP1 can be grouped
into three major types, Group A, B and C, suggesting their
stratification into separate and potentially functionally distinct
groups [7,8,9]. This basic concept has now been confirmed using
sequence information from additional clinical and laboratory
isolates [10]. We (Bull and colleagues) developed a sequence
classification system based on a small semi-conserved area of the
DBLa-domain of PfEMP-1, the DBLa-tag, which allows classifi-
cation of the entire var gene repertoire of clinical isolates. The
amino acid sequence of amplified DBLa-tags can be grouped
according to the number of cysteine (cys2 or cys4), the presence of
sequence signatures at ‘‘Positions of Limited Variation’’ (PoLV)
and through sharing of a limited number of sequence blocks within
the hypervariable regions [11,12]. A schematic diagram of the
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DBLa-tag is shown in the Figure S1. Using this system we
showed differential expression of distinct subgroups of var genes
in parasite isolates from children suffering from different
syndromes of severe disease and in non-immune children
[11,13]. Importantly, a subgroup of DBLa-tags that share blocks
of diverse sequence overlap with group A var genes identified in
the 3D7 genome [12] and are independently associated with
young host age and severe malarial syndromes [3]. Although
likely, whether serologically and genetically defined subgroups of
PfEMP1 identify the same group of variants has not yet been
determined.
T-cells play a critical role in protection, not only by providing
help to B cells but also through the secretion of cytokines that
activate macrophages and may have parasiticidal activity (re-
viewed in [14]. Rodent models of malaria have repeatedly shown
that T-cells are essential for early control of parasitaemia and that
elimination of parasites is dependent on both T and B-cells
[15,16]. To date, only a few studies have analysed T-cell responses
to PfEMP1 using either recombinant domains or peptides based
on a very limited number of PfEMP1 molecules identified in
laboratory isolates. These studies showed that a proportion of
malaria-exposed children and adults responded to DBLa or exon2
by proliferation or cytokine secretion in an antigen-specific
manner [17,18]. In both studies, proliferation of CD4+ T-cells
in response to antigen was observed in a small number of
unexposed European blood donors after seven days of culture.
Under these conditions, priming of naive T-cells occurs in culture
and it can not be determined whether the apparent CD4+ T-cell
response of unexposed European blood donors was non-specific or
an antigen-specific response of naive CD4+ T-cells [19]. By
contrast, CD4+ T-cell responses to one CIDRa domain were
observed in both malaria-exposed and unexposed individuals but
only the response in malaria-exposed individuals was MHC class
II restricted [17,20]. However, the use of recombinant domains
representing PfEMP1 expressed on laboratory isolates as described
in these studies may not capture T-cell responses specific for
PfEMP1 expressed on parasite(s) circulating within a population
and therefore miss a significant proportion of responses.
We were interested in whether there are differences in the type,
magnitude or duration of CD4+ T-cell responses to PfEMP1
dominantly expressed at the time of acute disease in children
suffering from severe malaria or infected with parasites expressing
specific subgroups of PfEMP1. We expressed recombinant DBLa-
tags from parasites isolated from clinical cases of malaria and
determined CD4+ T-cell responses in those children who provided
the clinical parasite isolate at the time of acute disease and during
convalescence. Although the DBLa-tag is only a small part of the
entire PfEMP1 molecule, it can serve as a model antigen to
determine whether a specific subset of PfEMP1 is associated with a
particular type of immune response.
Here we show that the magnitude, duration and type of DBLa-
tag specific CD4+ T-cells responses were not different between
children with severe or mild malarial symptoms. However, a small
group of children infected with parasites expressing group A
variants of PfEMP1 were more likely to induce antigen-specific
IFNc-secreting CD4+ T-cells 16 weeks after follow-up indicating
that the quality of T-cell responses to group A PfEMP1 differs
from those induced against the more diverse non-GroupA
PfEMP1. Surprisingly, we observed CD4+ T-cell responses to
heterologous DBLa-tags (DBLa-tags from a clinical isolate a child
was not infected with) in a sub-group of children tested despite the
extreme sequence diversity of DBLa-tags. These data suggested
that DBLa-tags contain a number of shared T-cell epitopes that
may be recognised by cross-reactive CD4 T-cells.
Results
Phenotype of T-cell responses to PfEMP1 during acute
disease and follow-up
The main aim of this study was to analyse the magnitude,
duration and phenotype of CD4+ T-cell responses to the PfEMP1
variant expressed in parasites infecting individual children during
acute disease and convalescence. PBMCs collected at presentation,
4 weeks and 16 weeks after the acute attack were stimulated
with the DBLa-tag (EMBL accession nos. FR874861-FR874900,
HE611335) representing the dominant PfEMP1 expressed on the
parasites a given child was infected with at the time of acute
disease and determined the proportion of DBLa-tag-specific CD4
T-cells producing either IFNc, IL10, IL2 or IL4 (Figure 1). We
used the expression homologous DBLa-tags to identify CD4+ T-
cell responses to the DBLa-tag derived from the clinical isolate a
given child was infected with and heterologous DBLa-tags to
identify CD4+ T-cell responses to DBLa-tags derived from clinical
isolates of other children. Baseline haematological parameters are
described in Table 1.
The majority of children (85%, n= 35) induced CD4+ T-cells
producing at least one of the tested cytokines IL2, IL4, IL10 and
IFNc in response to activation with the homologous DBLa-tag
during acute disease (Figure 2). Antigen-specific, cytokine pro-
ducing CD4+ T-cells were detected in 58% (n= 24) and 46%
(n= 20) of children 4 weeks and 16 weeks after the acute malaria
attack, respectively. The proportion of antigen-specific, cytokine-
producing CD4+ T-cells was comparable between different time
points (Mann Whitney U test, p.0.05) although the number of
children mounting a CD4+ T-cell response to the homologous
DBLa-tag dropped significantly for CD4+IFNc+, CD4+IFN-
c+IL10+ and CD4+IL2+IL4+ T-cells over the 4 months following
the acute episode (Pearson’s x2 for trend, p,0.05; Table 2).
To describe changes in the type of CD4+ T-cell responses over
time, we classified the CD4+ T-cell response to homologous
DBLa-tags as a Th1 or Th2 response, CD4+IL2+ or CD4+IL10+
only response, a mixed response, no response. During acute
disease, CD4+ T-cells from 11 children (27%) produced IFNc
either alone or together with IL2 (n= 8) indicative of a Th1
response. This profile was maintained in 3 children for 4 weeks
and in only 1 child for 16 weeks whereas 6 children showed a Th1
profile during the follow-up period but not during acute disease
(Figure 3A). We detected a Th2 profile (defined by secretion of IL4
either alone (n = 4) or together with IL2 (n= 4) and/or IL10 (n= 3)
in the absence of any CD4+IFNc+ T-cells) in 4 children at acute
disease but only one child maintained this profile over the entire
period of 16 weeks. By contrast, 4 and 6 children gained
CD4+IL4+ T-cell responses to the DBLa-tag at 4 weeks and 16
weeks, respectively, shifting from either a Th1 or mixed Th1/Th2
response at acute disease to a Th2 response in all but one child.
Antigen-specific, CD4+IL10+ T-cells were detected in 11
children either alone (n = 5) or together with CD4+IFNc+ T-cells
(n = 5). Four weeks after the acute episode, 6 children showed a
sole CD4+IL10+ T-cell response, which was maintained in 3
children or switched from a CD4+IFNc+ T-cell response either
alone or mixed with CD4+IL10+ T-cells (n = 3). We detected
IFNc+IL10+ double producing CD4+ T-cells in seven children
(n= 7) but only in combination with either CD4+IL10+ or
CD4+IFNc+ T-cells. With the exception of one child, DBLa-tag
specific CD4+IFNc+IL10+ T-cells were observed only at the time
of acute disease. Although not significant, children who mounted
DBLa-tag specific IFNc+IL10+ double producing CD4+ T-cells
tended to have a higher parasitaemia at acute disease (median
(25th and 75th interquartile) 255,680 parasites/ml blood (191,855–
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337,230) in children with IFNc+IL10+ double producing CD4+
T-cells and 148,240 parasites/ml blood (65,080–256,470) in those
without; Mann Whitney p= 0.08).
A small proportion of children displayed only CD4+IL2+ T-
cells in response to the homologous DBLa-tag at acute disease
(n = 6) indicating that these T-cells were primed but not yet fully
differentiated. IL2-producing CD4+ T-cell responses in the
absence of any other cytokine-producing T-cells were also
observed during follow-up but only in those children that either
induced no CD4 T-cell response or a Th1 response during acute
disease.
Together these results indicate that during acute malaria
disease, CD4+ T-cell responses are dominated by a Th1 response
sometimes in combination with IL10-producing CD4+ T-cells. By
contrast, CD4+ T-cell responses 4 weeks and 16 weeks following
the acute attack showed a more focused profile in those children
that maintained a DBLa-tag specific response.
CD4+ T-cell responses to DBLa-tags in children with
severe disease
We wondered whether children suffering from severe, life-
threatening malaria differed with respect to the magnitude,
duration or type of CD4+ T-cells responses specific for the
homologous DBLa-tag from children suffering from moderate
malaria. Children with severe malaria were similar with respect to
age, WBC and RBC count or Hb concentration to children with
mild to moderate malaria. There were no differences in either the
number of responders or the magnitude of cytokines produced by
CD4+T-cells in response to homologous DBLa-tags between
children suffering from severe or mild malaria either during acute
disease or over the 4 months follow-up period. Likewise, there was
no difference in the overall DBLa-tag specific T-cell profiles
between children with severe disease and mild disease (Figure 3B).
T-cell responses to different subsets of DBLa-tag
Expression of cys2 PfEMP1 and within these, the subgroup of
group A-like PfEMP1, had been associated with severe disease and
with low levels of existing immunity in young children [3]. We
therefore determined the var gene classification of each recombi-
nant DBLa-tag and compared CD4+ T-cell responses in children
infected with parasites that expressed one dominant cys-2 PfEMP1
(n= 12) or Group A-like PfEMP1 (n= 5, a subgroup of cys2
sequences) with those that did not. As with severe disease, these
children did not differ with respect to age, WBC, RBC counts or
Hb. Cys2 PfEMP1 were expressed on clinical isolates from three
children suffering from severe malaria and nine children suffering
from non-severe malaria. However, children infected with
parasites that expressed one dominant cys2 PfEMP1 showed a
higher proportion of DBLa-tag specific CD4+IL10+ T-cells
(median (25th and 75th percentile): 0.13 (0–0.28) for cys2 DBLa-
tags; 0 (0–0) for non-cys2 DBLa-tags, Mann Whitney U test
p = 0.015) and a higher frequency of responders (6/9 responders
for cys2; 5/27 responders for non cys2, Pearson’s x2 = 7.4, df = 1,
p = 0.007) during acute disease than children infected with
parasites that expressed a dominant non-cys2 PfEMP1 (Figure 4).
Conversely, the phenotype of the CD4+ T-cell response in
children infected with parasites that expressed a dominant cys2
PfEMP1 at acute disease changed to a predominantly IFNc+
response, both with respect to the number of children (3/6
responders for cys2; 2/18 responders for non cys2, Pearson’s
x2 = 4.1, df = 1, p = 0.042) and the magnitude of the response
(median % of CD4+ T-cells (25th and 75th percentile): 0.03 (0–
0.23) for cys2 DBLa-tags; 0 (0–0) for non-cys2 DBLa-tags, Mann
Whitney U test p = 0.049) 16 weeks after the acute episode.
However, this trend was driven by a subgroup of children infected
with parasites that expressed a dominant Group A-like PfEMP1 at
acute disease (median % of CD4+ T-cells (25th and 75th
Figure 1. Gating Strategy used to identify T-cell responses. PBMCs were gated to eliminate doublets and dead. CD3+lymphocytes were
identified and gated for CD4+ and CD8+ T-cells. Within each T-cell subset, the proportion of IFNc, IL10, IL2, and IL4 producing cells were determined.
IFNc+IL10+ and IL2+IL4+ double producers were determined by Boolean gating.
doi:10.1371/journal.pone.0030095.g001
Table 1. Baseline characteristics of study population.
Acute
episode
4 weeks
follow up
16 weeks
follow up
age (months) 42.1 (25.6–57.4) 43.1 (26.6–58.4) 46.1 (29.6–61.4)
parasite density
(103/ml)
190 (100–369) 0a 0b
WBC (106/ml) 8.4 (6.6–13.7) 8.2 (6.4–12.4) 9.1 (7–10.3)
RBC (109/ml) 4 (3.5–4.5) 4.8 (4.2–5.4)* 4.8 (4.2–5.1)*
Hb (g/dl) 9.2 (7.4–10.2) 10.6 (9.5–12)* 10.7 (9.4–11.9)*
Shown are median and in parenthesis 25th and 75th percentile.
*p#0.05 compared to acute disease, Wilcoxon signed rank test.
aone child had a parasite density of 514/ml blood 4 weeks after the acute event.
bone child had a parasite density of 1386103/ml blood 16 weeks after the acute
event.
doi:10.1371/journal.pone.0030095.t001
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percentile): 0.13 (0.05–0.3) for group A DBLa-tags; 0 (0–0) for
non-group A DBLa-tags, Mann Whitney U test p = 0.005; 3/5
responders for group A; 2/20 responders for non group A,
Pearson’s x2 = 8.5, df = 1, p = 0.003). In summary, cys2 DBLa-tags
induced CD4+ T-cell responses that differed in phenotype and
magnitude from CD4+ T-cell responses induced by non-cys
DBLa-tags suggesting that parasites that express a dominant cys2
PfEMP1 induced a different CD4+ T-cell response compared to
parasites that express a dominant cys2 PfEMP1.
T-cell responses to heterologous DBLa-tags
For some children we had sufficient number of PBMCs to
evaluate CD4+ T-cell responses to another, heterologous DBLa-
tag. The heterologous DBLa-tag tested was chosen randomly from
a child tested at the same day. Overall, we analysed heterologous
responses in 14 children during acute disease, in 16 children 4
weeks and in 10 children 16 weeks after the acute malaria episode.
In total, CD4+ T-cell responses to 25 pairs of homologous and
heterologous DBLa-tag were compared at one or more time
points. The pairwise identity between homologous and heterolo-
gous DBLa-tags ranged from 33.6% to 56.7% (Table S1). For only
four pairs, both the homologous and the heterologous DBLa-tag
were classified as cys2 PfEMP1. CD4+ T-cell responses to
heterologous DBLa-tags varied between children, with some
children inducing no CD4+ T-cell response, a similar CD4+ T-cell
response profile or a different CD4+ T-cell response profile to the
heterologous DBLa-tags compared to the homologous DBLa-tag
(Figure 5A). There was no obvious tendency for either a similar or
different type of CD4+ T-cell response to the heterologous DBLa-
tag compared to the homologous DBLa-tag (Figure 5B). These
data suggest that some children had been exposed to T-cell
epitopes similar to those observed in the heterologous DBLa-tag
before.
Figure 2. Percentage of CD4+ T-cells producing cytokines after
stimulation with the homologous DBLa-tag. PBMCs from children
obtained during acute malaria, 4 weeks and 16 weeks after the acute
event were stimulated with recombinant DBLa-tag representing the
dominant expressed PfEMP1 a given child was infected with. CD4+ T-
cells were stained for production of INFc and IL10 or IL2 and IL4 by
intracellular cytokine staining. Shown are dot plots of percentages of
CD4+ T-cells producing the indicated cytokine or cytokine combination
during acute malaria or 4 and 16 weeks after the acute episode.
Horizontal lines indicate the median.
doi:10.1371/journal.pone.0030095.g002
Table 2. Magnitude of cytokine secretion by CD4+ T-cells after stimulation with DBLa-tags.
Acute episode 4 weeks follow up 16 weeks follow up
IFNc+ Median all 0.017 (0–0.18) 0 (0–0.02) 0 (0–0.025)
N (%) responders* 15 (36.5%) 6 (14.6%) 5 (12.2%)
Median responders 0.27 (0.08–0.42) 0.16 (0.09–0.54) 0.2 (0.06–0.34)
IL10+ Median all 0 (0–0.11) 0 (0–0.06) 0 (0–0.005)
N (%) responders 11 (26.8%) 10 (24.3%) 5 (12.2%)
Median responders 0.25 (0.14–0.42) 0.2 (0.08–0.61) 0.15 (0.08–0.33)
IFNc+IL10+ Median all 0 (0–0.007) 0 (0–0) 0 (0–0)
N (%) responders* 7 (17%) 1 (2.4%) 1 (2.4%)
Median responders 0.15 (0.08–0.61) na na
IL2+ Median all 0.06 (0–0.27) 0 (0–0.1) 0.008 (0–0.27)
N (%) responders 15 (36.5%) 9 (22%) 9 (22%)
Median responders 0.22 (0.14–0.5) 0.21 (0.1–0.69) 0.34 (0.07–0.55)
IL4+ Median all 0 (0–0.038) 0 (0–0.025) 0 (0–0.12)
N (%) responders* 8 (19.5%) 5 (12.2%) 7 (17%)
Median responders 0.18 (0.05–0.78) 0.13 (0.06–0.92) 0.19 (0.1–0.62)
IL2+IL4+ Median all 0.004 (0–0.008) 0 (0–0.008) 0.002 (0–0.011)
N (%) responders 11 (26.8%) 3 (7.3%) 2 (4.8%)
Median responders 0.1 (0.05–0.18) 0.06 (0.05–0.28) 0.04, 1.7
*p#0.05, Pearson’s x2 for reduction in the number of responders over time.
doi:10.1371/journal.pone.0030095.t002
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When we considered CD4+ T-cell responses to cys2 DBLa-tags
and non-cys2 DBLa-tags for the homologous and heterologous
DBLa-tags together, we observed a similar trend with respect to
the differences in the type duration and magnitude of CD4+ T-cell
responses. Overall, the magnitude of CD4+ T-cells responses and
the proportion of responders was higher when PBMCs were
stimulated with cys2 DBLa-tags or group A DBLa-tags compared
to stimulation with non-cys2 DBLa-tags (Figure 6). Comparable to
CD4+ T-cell responses to the homologous DBLa-tag, a higher
percentage of CD4+IL10+ T-cells (median % of CD4+ T-cells
(25th and 75th percentile): 0.13 (0–0.34) for cys2 DBLa-tags; 0 (0–
0) for non-cys2 DBLa-tags, Mann Whitney U test p = 0.003) and a
higher proportion of responders (10/15 responders for cys2; 8/38
responders for non cys2, Pearson’s x2 = 9.9, df = 1, p= 0.002) was
detected during acute disease whereas CD4+IFNc positive T-cells
dominated 16 weeks after the acute attack with respect to the
number of responders (5/10 responders for cys2; 5/31 responders
for non cys2, Pearson’s x2 = 4.7, df = 1, p = 0.03). Likewise, the
number of responders inducing CD4+IL10+ T-cells after
stimulation with group A-like DBLa-tags was higher compared
to other DBLa-tags during acute disease (5/7 responders for group
A; 13/46 responders for non-group A, Pearson’s x2 = 5.05, df = 1,
p = 0.025) whereas induction of CD4+IFNc+ T-cells in response
to group A DBLa-tags dominated 16 weeks after the acute attack
(4/6 responders for group A; 6/35 responders for non group-A,
Pearson’s x2 = 6.8, df = 1, p = 0.009). Together, these data indicate
Figure 4. Cumulative percentage of cytokine producing CD4+ T-cells after stimulation with homologous DBLa-tag by PfEMP1
subgroup. Shown are cumulative bar-graphs of CD4+ T-cells producing cytokines indicated for each child. Data are grouped by the PfEMP1 subclass
of the homologous DBLa-tag at acute disease, week 4 and week 16 after the acute event. Children suffering from severe disease are indicated by a
star. Note that the order of children is the same in each plot.
doi:10.1371/journal.pone.0030095.g004
Figure 3. Phenotype of CD4+ T-cells stimulated with the
homologous DBLa-tag. The phenotype of CD4+ T-cell in response
to the homologous DBLa-tag was classified for each child and time
point as followed: Th1, secretion of IFNc alone or together with IL2 and/
or IFNc+IL10+; Th2, secretion of IL4 alone or in the presence of CD4+ T-
cells secreting IL2 or IL10; IL2 alone: detection of only IL2-producing
CD4+ T-cells; IL10 alone: detection of only IL10-producing CD4+ T-cells;
mixed: detection of a mixed profile such as IFNc-producing CD4+ T-cells
together with IL4- or IL10-producing CD4+ T-cells or IL2- and IL10-
producing CD4+ T-cells; none: children who did not induce any antigen-
specific CD4+ T-cells. Shown are pie charts of the proportion of all
children (A) with a particular profile or (B) grouped by disease severity.
doi:10.1371/journal.pone.0030095.g003
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that cys2 PfEMP1, and particularly group A PfEMP1, may induce
a different T-cell response than non-cys2 PfEMP1.
Discussion
Here we report that DBLa-tag-specific T-cell responses are
readily detected in children with acute malaria and can be
identified 16 weeks after the acute episode in a proportion of
children indicating that some of them may induce long-lasting
effector T-cells. Importantly, the DBLa-tag used as antigen here
was identified as the dominant PfEMP1 expressed on the clinical
parasite isolate circulating in a given child and thus we measured
T-cell responses to the individual PfEMP1 variant a child was
actually exposed to.
Obviously, our approach has limitations. First, the entire
PfEMP1 molecule will harbour many more T-cell epitopes and
some of those lying outside the DBLa-tag may be more dominant.
Second, we assumed that the T-cell phenotype(s) we detected using
the DBLa-tag as an antigen will reflect the T-cell phenotype
induced by the entire PfEMP1 molecule since activation of T-cell
recognizing different epitopes of one PfEMP1 variant will occur in
a similar environment with respect to co-stimulation and cytokines
provided by antigen presenting cells. However, different parts of a
given molecule may be processed at different rates and thus may
affect epitope density or delays in T-cell priming by dendritic cells
with consequences for T-cell function [21]. Bearing these
assumptions in mind, we nevertheless made significant observa-
tions. First, we detected DBLa-tag specific IFNc and IL10+
double-producing CD4+ T-cells in a proportion of children.
Second, CD4+ T-cell responses to cys2 DBLa-tag showed a
distinct profile with IL10 secretion during acute disease but IFNc
secretion 16 weeks after the acute event. Finally, we detected
CD4+ T-cell responses to heterologous DBLa-tags despite
considerable sequence diversity between DBLa-tags suggesting
that at least some T-cell responses may be cross-reactive.
The majority of children responded to the homologous PfEMP1
by induction of CD4+IFNc and CD4+IL2+ producing T-cells,
indicating a Th1 profile either alone or in combination with IL10-
secreting CD4+ T-cells. In addition, we detected IFNc and IL10+
double-producing CD4+ T-cells, which have recently been
described [22]. These T-cells reflect a normal differentiation
process in Th1 responses providing a negative feedback loop in the
presence of high antigen load or high concentrations of IL12 and
are thought to regulate an otherwise dangerous inflammatory
response. Most IL10-producing Th1 T-cells co-produce IFNc but
sole production of IL10 after repeated stimulation has been
reported [23,24,25,26,27]. Importantly, IL10-producing Th1 cells
switch to IFNc production after a period of rest and some authors
now suggest that at least some of the IL10-producing Tr1 cells
may present late stages of Th1 [28]. In agreement with these
studies, children with IL10-producing Th1 T-cells tended to have
high parasitaemia during acute disease. IL10-producing Th1 T-
cells had first been described over two decades ago but to our
knowledge this is the first report of these cells in malaria [29].
When we analysed CD4+ T-cell responses by PfEMP1
subgroup, we observed that children infected with parasites
Figure 5. CD4+ T-cells responses response to homologous or heterologous DBLa-tags. (A) Representative examples of CD4+ T-cell
responses to homologous and heterologous DBLa-tags for 6 children. Pie charts indicate the IFNc+ (red), IL10+ (blue) and IFNc+IL10+ double
producing (green) CD4 T-cells as a proportion of the total cytokine producing CD4+ T-cells. White circles indicate the absence of a response. Within
each cells, the sequence of circles indicates the proportion of CD4+ T-cells at acute disease (left), and 4 weeks (middle) and 16 weeks (right) after the
acute episode. (B) Dot plots of the percentage of CD4+ T-cell responses to homologous (homo) and heterologous (hetero) DBLa-tags during acute
malaria or 4 and 16 weeks after the acute attack. Horizontal lines indicate the median.
doi:10.1371/journal.pone.0030095.g005
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expressing a cys2 PfEMP1 tended to mount IL10+ CD4+ T-cells
during acute disease but displayed IFNc+ CD4+ T-cell responses
16 weeks after the acute episode, the later was driven by group A-
like DBLa-tags. When we considered all cys2 DBLa-tags tested
independent of whether they reflected heterologous or homolo-
gous responses, we noted a similar trend to that observed with
homologous cys2 DBLa-tag. The shift from a T-cell response
dominated by IL10 at acute disease to one dominated by IFNc
may be the result of a regulatory response to inflammation either
due to normal differentiation of Th1 T-cells or due to induction of
IL-10-producing regulatory T-cells [22,28]. During acute disease,
high antigen-load and pro-inflammatory conditions may favour
switching of Th1 cells to the production of IL10 [28].
Alternatively, antigen-specific Th1 T-cells may redistribute to
the spleen during acute disease and re-enter the circulation only
after the infection has been cleared [30]. To differentiate between
these options, both IL10- and IFNc-producing DBLa-tag specific
T-cells require further characterisation. Nevertheless, pending
confirmation in a larger group of children, our results indicate that
cys2 DBLa-tags and within this subset, group A-like DBLa-tags
may induce a stable Th1 effector memory response that may
contribute to the rapid acquisition of immunity to this particular
subset of PfEMP1 variants. Although we can not exclude the
possibility that antigen-specific T-cell responses detected 4 and 16
weeks after the acute episode were due to additional infections, it
seems unlikely because all children were tested for presence of
parasites by microscopy at the clinical examination during follow-
up visits and they occurred mainly during the dry season when
transmission is low. Stable populations of effector memory T-cells
have been reported in humans in a rodent model of malaria
[31,32]. Both cys2 and Group A PfEMP1 variants are frequently
expressed in non-immune hosts such as young children but also in
children suffering from severe malarial disease [3]. Thus, memory
CD4+ T-cells specific for cys2 and Group A PfEMP1 may be
induced during the first few infections and if they were expressed
early in later infections but maybe not maintained due to negative
immune-selection, adaptive immune responses against group A
PfEMP1 variants might be boosted resulting in the maintenance of
effector memory T-cells.
We were able to test CD4+ T-cell responses to heterologous
DBLa-tags in a small subset of children. Overall, heterologous
responses varied both between antigens and between patients with
no obvious trend towards reduced or increased antigen-specific
CD4+ T-cell responses or the proportion of responders. CD4+ T-
cell responses to heterologous DBLa-tags probably reflect previous
or concurrent exposure of individual children to PfEMP1 variants
with similar DBLa-domains either during the current or a
previous infection. In all clinical isolates, more then one DBLa-
tag sequence was detected probably representing expression of
switched PfEMP1 or infection with additional parasite clones.
Thus, all children in this study were exposed to more then one
PfEMP1 variant over the course of acute infection and could have
mounted an immune response to various DBLa-tag. However,
over its entire length, different DBLa-tags and indeed DBLa
domains show only limited identity and a large study on more than
14,000 DBLa-tag sequences in Kilifi, Kenya observed only a small
number of identical sequences [13]. Therefore, chance exposure to
the PfEMP1 represented by the heterologous DBLa-tag seems
highly unlikely. By contrast, this observation suggests that the
DBLa-tag region contains T-cell epitopes that are relatively
conserved and shared between several DBLa domains. Indeed, a
study by Sanni et al. suggested that targets of CD4+ T-cell
responses to PfEMP1 are relatively conserved because they
detected CD4+ T-cell responses to pools of peptides derived from
semi-conserved blocks of 15 variants of PfEMP1 [18]. Our own
preliminary analysis of predicted T-cell epitopes within the 41
DBLa-tags showed that predicted high affinity peptides often span
semi-conserved areas. For instance the region between PoLV3 and
PoLV4 shows distinct sequence signatures (also known as
homology blocks) that differentiate between cys2 and cys4
DBLa-tags [10]. In our preliminary analysis we observed a higher
proportion of peptides predicted to bind to MHC class II alleles in
cys2 DBLa-tags than in cys4 DBLa-tags. Cross-recognition of
peptides from a subset of antigenically restricted PfEMP1 within
MHC class II supertypes would allow rapid activation of memory
T-cells that can provide help to B-cells specific for the cognate
antigen and may result in earlier and more efficient antibody
responses. CD4+ T-cell epitopes may not be subjected to the same
degree of immune selection as B-cell or CD8 T-cell epitopes
because CD4+ T-cell effector function is often indirect through
activation of other cell types, their frequency is generally lower
than that of CD8+ T-cells and protection conferred by CD4+ T-
Figure 6. CD4+ T-cells responses response to cys2 and non-cys2 DBLa-tags. Dot plots of the percentage of CD4+ T-cell responses to cys2
and non-cys2 DBLa-tags whether or not they represent homologous or heterologous DBLa-tags during acute malaria or 4 and 16 weeks after the
acute attack. Horizontal lines indicate the median.
doi:10.1371/journal.pone.0030095.g006
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cells in other infections usually limits disease severity but does not
induce sterile protection [33,34].
In summary, our data suggest that DBLa-tags from group A
PfEMP1 may contain a limited set of T-cell epitopes that are
shared between variants of group A DBLa-tags. If this were the
case, subsequent encounter of group A PfEMP1 might activate
cross-reactive CD4 T-cells that can provide rapid help to B cells.
This hypothesis is testable using a combination of bioinformatic
approaches and cellular assays. If it can be confirmed, the design
of vaccines targeting PfEMP1 variants associated with severe, life
threatening illness may become feasible.
Methods
Ethics Statement
The study was approved by the Kenyan National Ethics Review
Committee (protocol no. 1131) and the Oxford Tropical Research
Ethics Committee (protocol no. 30-06). Parents or Guardians of
the children provided written informed consent.
Study cohort
We analysed blood samples from 41 children with acute malaria
attending Kilifi District Hospital between 2006 and 2009. After
parents or guardians provided informed consent for participation
of their children in the study, children donated a venous blood
sample of 3 ml at presentation with acute malaria, and 4 weeks
and 4 months after the acute episode. Children who were admitted
with impaired consciousness (Blantyre Coma Score ,5), severe
anaemia (Hb ,5 g/dl and at least 10,000 parasites/ml blood) or
severe respiratory distress (deep breathing and chest recession)
were classified as suffering from severe malaria (n = 9). During
follow-up visits, children were clinically examined, tested for the
presence of Plasmodium species by microscopy and received a
differential blood count. Children who were acutely ill received
medical treatment as required. Parents or Guardians of the
children provided informed consent.
Processing of blood samples
Heparinised blood was spun at 2000 rpm, plasma removed,
aliquoted and stored at 280uC. The remaining blood cells were
diluted to a total volume of 5 ml in RPMI before separation of
peripheral blood mononuclear cells (PBMC) with lymphoprep.
PBMC were washed twice with RPMI, resuspended in 10%
DMSO/FCS and stored in liquid nitrogen. The remaining red
blood cells (RBCs) were washed twice in RPMI and RBCs and
granulocytes were separated by plasmagel flotation. 100 ml of
packed RBCs were resuspended in 800 ml Trizol and stored at
280uC for extraction of RNA.
Isolation and expression of dominant expressed DBLa
tags
Dominant expressed PfEMP1 were identified in 41 clinical
isolates by the method described in detail elsewhere [11] with the
difference that we identified, classified and expressed the single
transcript that was most abundant. In brief, RNA was extracted
from RBCs, converted to cDNA and amplified using DBLaAF9
(59-GCACG(A/C)AGTTT(C*/T)GC-39) and DBLaBR (59-GC-
CCATTC(G/C)TCGAACCA-39) primers targeting a semi-con-
served region of the DBLa-domain. PCR-products were cloned
into pCR2.1 cloning vector, plasmid extracted from 10–20
colonies and sequenced on an Applied Biosystems 3730 sequencer
using Big Dye Terminator v.3.1 cycle sequencing. The dominant
DBLa-tag sequence was identified (range 10%–85% of sequenced
transcripts), amplified from a representative plasmid by PCR using
the DBLaAF9 primer and a DBLaBR primer containing a 39-stop
codon (59-TTAGCCCATTC(G/C)TCGAACCA-39). PCR prod-
ucts were ligated into the pEXP5(NT) TOPO vector (Invitrogen)
containing and N-terminal His-tag sequence, transformed into
TOP10 cells and the insert confirmed by sequencing. The DBLa-
tag-containing plasmids were transformed in BL21 DE3pLysS E.
coli (Invitrogen). Individual colonies were grown to an OD600 of
0.4, protein expression induced with 1 mM IPTG, and cells grown
for another 4 hours. The cell pellet was harvested by centrifuga-
tion and lysed with Bugbuster NT (Novagen) in the presence of
Benzonase (Novagen). All DBLa-tags formed inclusion bodies and
were purified under denaturing condition on Probond Nickel-
chelating resin (Invitrogen) according to manufacturers recom-
mendation. Purified proteins were dialysed over 24 hours against
20 mM TrisHCl, 50 mM NaCl, 6 M Urea pH 4.5 with stepwise
reduction of the Urea concentration. Final dialysis was against
20 mM TrisHCl, 50 mM NaCl pH 4.5 for 12 hours. Contami-
nating endotoxin was removed using Endotrap blue (Hyglos
GmbH) according to manufacturers recommendation and the
residual endotoxin concentration was determined using the
Limulus amoebae-lysate assay (Cambrex Bioscience) according
to manufacturers recommendation. The residual endotoxin
concentrations ranged from 0.0004–0.003 U/mg protein. The
final protein concentration was determined using the BCA assay
(Pierce). Recombinant proteins were sterile-filtered with 0.2 mm
syringe filters and stored at 280C.
Intracellular cytokine staining
PBMCs from acute and convalescent samples were thawed and
0.56106 cells seeded twice in triplicate into 96 well plates in medium
(RPMI1698 supplemented with 5% pooled human AB serum,
5 mM glutamine, 10 mM Hepes, 50 mM b-mercaptoethanol,
50 mM kanamycin). Cells were rested overnight before activation
with medium alone, 20 mg/ml homologous recombinant DBLa-tag
or anti-CD2/CD3/anti-CD28-coated MACSiBead particles (Mil-
tenyi Biotec) in the presence of 1 mg/ml CD28 and CD49d for
2 hours. Cells were incubated for another 18 hours in the presence
of brefeldinA. Cells were harvested and stained with ViViD Aqua
(Invitrogen) before intracellular cytokine staining was performed as
follows: Cells were fixed with Cytofix (Becton Dickinson) for 20 min
at RT in the dark, washed twice with Cytoperm (Becton Dickinson)
and subsequently stained in Cytoperm with CD3-ECD Beckman
Coulter), CD4-PC7 (Beckman Coulter), CD8-APC H7 (Becton
Dickinson) and either IFNc-FITC (R&D) and IL10-PE (Becton
Dickinson) or IL2-FITC (R&D) and IL4-PE (Becton Dickinson), for
1 hour at 4uC in the dark. Cells were washed twice, resuspended in
Sheath Fluid (Beckmann Coulter) and acquired on a Cyan Analyzer
(Beckmann Coulter) within 24 hours. Live, CD3+CD4+ or CD3+
CD8+ T-cells were identified and the proportion of IFNc+IL10-,
IFNc-IL10+ and IFNc+IL10+ T-cells was determined using FlowJo
Africa. Four samples with less than 1000 CD4+ T-cells (n= 2) or
failed positive response (cytokine secretion in less than 1% of CD4+
T-cells stimulated with microbeads, n= 2) after staining for CD4+
T-cells secreting IL2, IL4 or both were excluded from further
analysis. Values obtained from PBMCs incubated with medium
alone were subtracted from values obtained after activation of
PBMCs with DBLa-tags. When individual gates of cytokine-
secreting CD4+ T-cells had less then 10 positive events or their
percentage was below 0.03%, the response was recorded as zero.
Statistical data analysis
All data were analysed using PAWStatistics version 18.
Comparison of continuous variables between different groups
was done using Mann-Whitney rank sign test and for comparison
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of categorical variables the Pearson x2 or Fisher’s exact test was
used. P-values less than 0.05 were considered significant. For
graphic representation of data PAWStatistics version 18.0 and
Graphpad Prism version 5 was used.
Supporting Information
Figure S1 Schematic Overview of the DBLa domain
organisation. (A) Indicated is the relative position of homology
blocks (HB) 1–5 common to all DBL domains. Universal primers
amplifying the DBLa-tag target conserved sequences in HB3 and
HB2 and are indicated by black arrows. The ‘‘Positions of Limited
Variation’’ (PoLV) 1 to 4, which together with the number of
cysteine’s in each DBLa-tag form the basis of the DBLa-tag
classification. (B) Sequence signature of cys2 and cys4 DBLa-tags.
PoLV1-4 are indicated by blue brackets.
(TIF)
Table S1 *MUSCLE alignment, shown is the percentage
and in parenthesis the number of identical amino acids.
(DOC)
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